SCHEMBL7480845

SCHEMBL7480845

COc1ccc(S(=O)(=O)N2CN(Cc3ccccc3)C(=O)C(C)(C)[C@@H]2C(N)=O)cc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 12/20 0.58
MMP9 P14780 12/20 0.58
MMP3 P08254 10/20 0.58
MMP2 P08253 8/20 0.58
MMP8 P22894 3/20 0.58
MMP7 P09237 5/20 0.52
MMP13 P45452 7/20 0.49
LMNA P02545 1/20 0.47
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
PKM P14618 1/20 0.45
SIRT2 Q8IXJ6 1/20 0.44
SIRT1 Q96EB6 1/20 0.44
MMP12 P39900 1/20 0.43
MMP14 P50281 1/20 0.43
MMP15 P51511 1/20 0.43
MMP16 P51512 1/20 0.43
MMP26 Q9NRE1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7483182 0.81 MMP1 (0.79) MMP1MMP9MMP3MMP2MMP8
SCHEMBL7661343 0.78 MMP1 (0.48) MMP1MMP9MMP3MMP2MMP8
SCHEMBL7480347 0.76 MMP2 (0.81) MMP1MMP9MMP3MMP2MMP8
SCHEMBL7480352 0.76 MMP2 (0.81) MMP1MMP9MMP3MMP2MMP8
SCHEMBL4312415 0.73 MMP1 (1.00) MMP1MMP9MMP3MMP2MMP8
SCHEMBL7479388 0.73 MMP1 (0.75) MMP1MMP9MMP3MMP2MMP8
SCHEMBL7428159 0.72 MMP1 (0.80) MMP1MMP9MMP3MMP2MMP8
SCHEMBL7078092 0.71 MMP1 (0.62) MMP1MMP9MMP3MMP2MMP8
SCHEMBL5639168 0.71 MMP1 (0.61) MMP1MMP9MMP3MMP2MMP8
SCHEMBL5636276 0.69 MMP1 (0.73) MMP1MMP9MMP3MMP2MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0923561-B1 HETEROCYCLIC METALLOPROTEASE INHIBITORS PROCTER & GAMBLE (US) 2002-10-23 EP disclosed
US-6399598-B1 ORAL DISEASES; RHEUMATIC DISEASES; OSTEOPOROSIS THE PROCTER & GAMBLE COMPANY 2002-06-04 US disclosed
US-6121258-A FOR TREATMENT OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS, SKIN DISORDERS, OCULAR DISORDERS, INFLAMMATION, GUM DISEASE THE PROCTER & GAMBLE COMPANY (US) 2000-09-19 US disclosed